Skip to main content

Histochemistry of MAO subtypes in the brainstem of humans: a relation to the radical hypothesis of Parkinson’s disease?

  • Conference paper
Early Diagnosis and Preventive Therapy in Parkinson’s Disease

Part of the book series: Key Topics in Brain Research ((KEYTOPICS))

Summary

The distribution of monoamine oxidase subtypes in the human brain-stem is described. Results are discussed in relation to the MAO-B inhibiting therapy of Parkinson’s disease (PD). Additionally, attention is focused onto the pathogenesis of PD, especially on radical mechanisms which might be mediated via exotoxins and amplified by endogenous radicals.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Birkmayer W, Riederer P, Ambrozi L, Youdim MBH (1977) Implications of combined treatment with “Madopar” and 1-deprenyl in Parkinson’s disease. Lancet i: 439–443

    Article  Google Scholar 

  • Birkmayer W, Knoll J, Riederer P, Youdim MBH, Hars V, Marton J (1985) Increased life expectancy resulting from addition of 1-deprenyl to Madopar® treatment in Parkinson’s disease: A long-term study. J Neural Transm 64: 113–127

    Article  PubMed  CAS  Google Scholar 

  • D’Amato RJ, Alexander GM, Schwartzmann RJ, Kitt CA, Price DL, Snyder SH (1987) Neuromelanin: A role in MPTP-induced neurotoxicity. Life Sci 40: 705–712

    Article  PubMed  Google Scholar 

  • D’Amato RJ, Alexander GM, Schwartzmann RJ, Kitt CA, Price DL, Snyder SH (1987) Neuromelanin: A role in MPTP-induced neurotoxicity. Life Sci 40: 705–712

    Article  PubMed  Google Scholar 

  • Davis GC, Williams AC, Markey SP, Ebert MH, Calne ED, Reichert CM, Kopin IJ (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogous. Psychiat Res 1: 249–254

    Article  CAS  Google Scholar 

  • Heikkila RE, Hess H, Duvoisin RC (1985) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse: Relationships between monoamine oxidase, MPTP metabolism and neurotoxicity. Life Sci 36: 231–236

    Article  PubMed  CAS  Google Scholar 

  • Kinemuchi H, Fowler CJ, Tipton KF (1987) The neurotoxicity of 1-methyl4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its relevance to Parkinson’s disease. Neurochem Int 11 /4: 359–373

    Article  PubMed  CAS  Google Scholar 

  • Kishimoto S, Kimura H, Maeda T (1983) Histochemical demonstration for monoamine oxidase ( MAO) by a new coupled peroxidation method. Cell Mol Biol 29: 61–69

    PubMed  CAS  Google Scholar 

  • Konradi C, Riederer P, Youdim MBH (1986) Hydrogen peroxide enhances the activity of monoamine oxidase type-B but not of type-A: A pilot study. J Neural Transm [Suppl] 22: 61–73

    Google Scholar 

  • Perry TL, Godin DV, Hansen S (1982) Parkinson’s disease: A disorder due to nigral glutathione deficiency? Neurosci Lett 33: 305–310

    Article  PubMed  CAS  Google Scholar 

  • Perry TL, Yong VW, Clavier RM, Jones K, Wright JM, Foulks JG, Wall RA (1985) Partial protection from the dopaminergic neurotoxin N-methyl4-phenyl-1, 2, 3, 6-tetrahydropyridine by four different antioxidants in the mouse. Neurosci Lett 60: 109–114

    Article  PubMed  CAS  Google Scholar 

  • Riederer P, Jellinger K, Seemann D (1984) Monoamine oxidase and Parkinsonism. In: Tipton KF, Dostert P, Strolin-Benedetti M (eds) Monoamine oxidase and disease. Academic Press, London, pp 403–415

    Google Scholar 

  • Riederer P, Sofic E, Rausch W-D, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1988) Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brains. ( Submitted )

    Google Scholar 

  • Singer TP, Salach JI, Castagnoli N, Trevor A (1986) Processing of MPTP to toxic metabolites by monoamine oxidases. In: Markey SP, Castagnoli N, Trevor AJ, Kopin IJ (eds) MPTP: A neurotoxin producing a parkinsonian syndrome. Academic Press, London, pp 235–251

    Google Scholar 

  • Yong VW, Perry TL, Krisman AA (1986) Depletion of glutathione in brain-stem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment. Neurosci Lett 63: 56–60

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag/Wien

About this paper

Cite this paper

Konradi, C., Riederer, P., Heinsen, H. (1989). Histochemistry of MAO subtypes in the brainstem of humans: a relation to the radical hypothesis of Parkinson’s disease?. In: Przuntek, H., Riederer, P. (eds) Early Diagnosis and Preventive Therapy in Parkinson’s Disease. Key Topics in Brain Research. Springer, Vienna. https://doi.org/10.1007/978-3-7091-8994-8_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-8994-8_29

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82080-3

  • Online ISBN: 978-3-7091-8994-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics